Magazine Article | May 2, 2018

Fixing Trials Requires A True Commitment To Patient-Centricity

Source: Life Science Leader

By Ed Miseta, Chief Editor, Clinical Leader
Follow Me On Twitter @EdClinical

Everyone wants to improve clinical trial time, cost, and efficiency. The time and cost of performing trials continues to rise, as does the number of compounds that fail to make it through to consumers. Less than 12 percent of the drugs entering clinical testing will ultimately receive FDA approval. Even representatives of the FDA now admit our process for performing trials is “broken.”

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: